What is Tandem Diabetes Care's R&D?

Tandem Diabetes Care (TNDM) reported R&D of $46.04M in Q1 2026.

How has Tandem Diabetes Care's R&D changed year-over-year?

Tandem Diabetes Care's R&D decreased by 8.3% year-over-year, from $50.22M to $46.04M.

What is the long-term trend for Tandem Diabetes Care's R&D?

Over 4 years (2021 to 2025), Tandem Diabetes Care's R&D has grown at a 20.3% compound annual growth rate (CAGR), from $92.05M to $193.11M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Tandem Diabetes Care TNDM R&D

R&D at other companies

InsuletPODD

$89.7M+50.5%

MedtronicMDT

$671M-1.9%

MannkindMNKD

$17.23M+56.3%

AbbottABT

$767M+7.1%

OmnicellOMCL

$21.52M+4.8%

ICU MedicalICUI

$21.28M-8.6%

Other financials

Income statement

See full

Revenue$247.2M+5.5%

Gross profit$136.8M+15.5%

Operating income-$17.4M+85.6%

Net income-$20.4M+84.4%

EPS (diluted)-$0.30+84.8%

Balance sheet

See full

Cash & equivalents$179.3M+235%

Total debt$734.7M+49.0%

Total equity$132.4M-14.7%

Total assets$1.2B+25.1%

Cash flow

See full

Operating cash flow$11.1M+160%

CapEx$6.3M+111%

Free cash flow$4.8M+123%

Valuation

See full

Market cap$1.03B-23.6%

Enterprise value$1.58B-11.3%

P/S1×-0.4×

Profitability

See full

Gross margin54.9%+2.7pp

Operating margin-8.2%-2.9pp

Net margin-9.2%-3.1pp

FCF margin-0.8%-0.4pp

Returns & leverage

See full

Return on equity-65.7%-14.7pp

Debt / equity5.5×+2.4×

Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tandem Diabetes Care's R&D?: Tandem Diabetes Care (TNDM) reported R&D of $46.04M in Q1 2026.
How has Tandem Diabetes Care's R&D changed year-over-year?: Tandem Diabetes Care's R&D decreased by 8.3% year-over-year, from $50.22M to $46.04M.
What is the long-term trend for Tandem Diabetes Care's R&D?: Over 4 years (2021 to 2025), Tandem Diabetes Care's R&D has grown at a 20.3% compound annual growth rate (CAGR), from $92.05M to $193.11M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.